All Stories

  1. Human mass balance, pharmacokinetics and metabolism of rovatirelin and identification of its metabolic enzymes in vitro

    Article • Xenobiotica, February 2019, Taylor & Francis

    Dr Yoshikazu Abe

  2. Pharmacokinetics of mizagliflozin, a novel selective SGLT1 inhibitor, in rats

    Article • Xenobiotica, March 2018, Taylor & Francis

    Dr Yoshikazu Abe

  3. Non-clinical pharmacokinetic profiles of rovatirelin

    Article • Xenobiotica, January 2018, Taylor & Francis

    Dr Yoshikazu Abe

  4. Drug-drug interaction with the OAT inhibitor

    Article • Clinical Pharmacology in Drug Development, September 2015, Wiley

    Dr Yoshikazu Abe